Cdk / Crk抑制剂是一种细胞可渗透的吡唑并嘧啶酮化合物,可作为Cdks的有效,选择性和ATP竞争性抑制剂(IC | 50 | = 48 nM,15 nM,9 nM,10 nM,71 nM和Cdc2(Cdk1)/细胞周期蛋白B,Cdk2 /细胞周期蛋白E,Cdk3 /细胞周期蛋白E,Cdk5 / p35,Cdk7 /细胞周期蛋白H / MAT1和Cdk9分别为9 nM。它仅在高得多的浓度(分别为IC | 50 | = 839 nM,282 nM和754 nM)下抑制Cdk4 / cyclin D1,C Cdk/Crk Inhibitor is a cell-permeable pyrazolo-pyrimidinone compound that acts as a potent, selective, and ATP-competitive inhibitor of Cdks (IC|50|= 48 nM, 15 nM, 9 nM, 10 nM, 71 nM, and 9 nM for Cdc2 (Cdk1)/cyclin B, Cdk2/cyclin E, Cdk3/cyclin E, Cdk5/p35, Cdk7/cyclin H/MAT1, and Cdk9, respectively). It inhibits Cdk4/cyclin D1, Cdk6/cyclin D3, and GSK-3β only at much higher concentrations (IC|50|= 839 nM, 282 nM, and 754 nM, respectively) and exhibits little activity towards a panel of 60 other kinases. Cdk/Crk Inhibitor is a broad-spectrum growth inhibitor toward tumor cells, but not non-transformed quiescent fibroblasts.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Cdk/Crk inhibitor
CAS number:784211-09-2 molecular formula:C23H22Cl2N4O3
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | Q27075833 | SCHEMBL1179657 | Prednidib | HMS3229E20 | DTXSID60429556 | 1-(2,6-dichlorophenyl)-6-{[4-(2-hydroxyethoxy)phenyl]methyl}-3-(propan-2-yl)-1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one | Cdk/Crk Inhibitor | 1-(2,6-dichlorophenyl)-6-[[4-(2-hydroxyethoxy | ||
| CAS number | 784211-09-2 | molecular formula | C23H22Cl2N4O3 |
| molecular weight | 473.4 g/mol | Exact mass | - |
| PSA | 88.700 Ų | logp | 4.300 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





